Market Overview The histone deacetylase 8 market is experiencing development as HDAC8 inhibitor research identifies therapeutic potential in cancer and rare genetic disorders. The global HDAC8 market is projected to exceed USD 2.5 billion through 2030, driven by epigenetic cancer research, rare disease targeting, and clinical trial initiation. HDAC8 inhibitors target epigenetic pathway through...